MedPath

NEVIRAPINA MYLAN 200 mg COMPRIMIDOS EFG

NEVIRAPINA MYLAN 200 mg COMPRIMIDOS EFG

Pending
Register Number

75433

Prescription Type

Uso Hospitalario

Authorization Date

Feb 8, 2012

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number75433
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

NEVIRAPINAActive
Quantity: 200,00 mg
Name: NEVIRAPINA

ATC CLASSIFICATION (2)

J05A
J05AG

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.